ESLA

Conviction 15HealthcareScan · Mon, Aug 10, 2026

ESLA$0.7413+2.60%

ResistanceSupportVol 14Insider buy

Vol MA14 30.61K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Estrella Immunopharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.estrellabio.com ↗

Price0.7413

Change+2.60%

Gap+6.38%

Rel volume1.76×

Avg volume43.67K

Avg $ vol34.35K

SMA 200.7598

SMA 500.9150

SMA 2001.36

Price vs 50-18.99%

Price vs 200-45.59%

MA stackbearish

50/200 cross—

Supertrenddown · 0.9310

RSI (14)40

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D48 / 36

ADX (14)11

+DI / −DI22 / 17

RSI divergence—

MACD divergenceBullish

ATR %+10.10%

ADR %8.85%

52w high3.05

52w low0.7000

From 52w high-75.70%

Above 52w low+5.90%

New 52w highNo

SqueezeOn · 3d

Bollinger width20.23%

%B0.38

Donchian pos24.13%

Donchian high0.9400

Donchian low0.6781

AVWAP (52w high)1.58

vs AVWAP high-53.06%

AVWAP (52w low)0.7448

vs AVWAP low-0.47%

OBV trendUp

Chaikin MF (20)-0.25

Today vs 20d1.76×

Avg vol (14d)30.61K

Avg vol (20d)43.67K

Avg $ vol (20d)34.35K

Market cap31.9M

RS 3m (vs SPY)-48.81%

RS 6m (vs SPY)-59.38%

RS line new highNo

Trend template0/8

Technical rank7.4

1 week+5.90%

1 month-20.02%

3 months-41.17%

6 months-48.88%

1 year-11.96%

YTD-46.67%

P/E-2.44

P/B-6.05

P/S—

P/FCF—

EPS-0.3500

Div yield—

ROE247.87%

ROA-357.20%

Debt/Eq—

Current0.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-78.67%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value30.52M

Revenue—

Net income-2.29M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out43.03M

Employees—

ListedMon, Oct 2, 2023

Free float10.25M

Float %27.1%

Short interest54.45K

Days to cover1.2d

Short volume47.5%

Squeeze score23 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction15 / 100

Pattern quality—

Tech rank7.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.10

Support0.6836

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ESLA

All disclosures →

No recent disclosed trades by Congress in ESLA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ESLA · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Xu Jiandong Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-10-07	Buy	1K	$1K	2025-10-07	2026-04-29
Xu Jiandong Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-09-22	Buy	1K	$1K	2025-09-22	2026-04-29
Xu Jiandong Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-09-11	Buy	100	$104	2025-09-11	2026-04-29

SEC filings

EDGAR filings in ESLA · 1 recent

EDGAR →

8-K8-KShareholder voteTue, Jun 30, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.